RG

Redmile Group Portfolio holdings

AUM $1.36B
1-Year Est. Return 111.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+111.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$651M
AUM Growth
+$94.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
72
New
Increased
Reduced
Closed

Top Buys

1
+$37.5M
2
+$36.2M
3
+$33.9M
4
GILD icon
Gilead Sciences
GILD
+$31.7M
5
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$27.4M

Top Sells

1
+$38.8M
2
+$34.2M
3
+$27.6M
4
IPXL
Impax Laboratories, Inc.
IPXL
+$19.2M
5
CELG
Celgene Corp
CELG
+$14.3M

Sector Composition

1 Healthcare 82.16%
2 Consumer Staples 1.22%
3 Technology 0.7%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$11M 1.69%
568,100
+19,000
27
$10.4M 1.6%
228,218
+118,100
28
$8.71M 1.34%
1,574,379
-876,201
29
$8.57M 1.32%
+462,913
30
$8.29M 1.28%
+754,132
31
$8.21M 1.26%
+108,262
32
$7.93M 1.22%
+1,073,799
33
$7.91M 1.22%
288,000
+10,000
34
$6.36M 0.98%
326,652
+14,500
35
$5.74M 0.88%
2,473,787
+100,100
36
– –
0
37
$4.82M 0.74%
+213,033
38
$4.56M 0.7%
+245,400
39
$4.11M 0.63%
+32,485
40
$2.86M 0.44%
+165,020
41
$1.49M 0.23%
+53,100
42
$540K 0.08%
+20,800
43
$386K 0.06%
+2,583
44
$311K 0.05%
6,500
45
$281K 0.04%
+10,500
46
$238K 0.04%
2,627
-124,400
47
$210K 0.03%
+1,700
48
$90K 0.01%
+1,991
49
– –
-7,200
50
– –
-1,048,559
1
2
3